Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group Processes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07781319
What this trial is testing

Early Gastric Cancer in the Spanish EURECCA Registry

Who this might be right for
Early Gastric CancerGastric Adenocarcinoma
Corporacion Parc Tauli 600
Not applicableStudy completedNCT01152034
What this trial is testing

MAPS Group Therapy Model for Bipolar Disorder

Who this might be right for
Bipolar DisorderSuicide
Mackay Memorial Hospital 68
Testing effectiveness (Phase 2)Study completedNCT03815916
What this trial is testing

31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Clene Nanomedicine 13
Large-scale testing (Phase 3)Study completedNCT01539538
What this trial is testing

A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain

Who this might be right for
Post-Operative Pain
Talphera, Inc 357
Testing effectiveness (Phase 2)Study completedNCT02064426
What this trial is testing

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 88
Large-scale testing (Phase 3)Study completedNCT02072434
What this trial is testing

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 2,199
Not applicableUnknownNCT03027921
What this trial is testing

Validation in a Non-targeted Population of Single Ultrasound Doppler Signs of Liver Fibrosis

Who this might be right for
Cirrhosis
University Hospital, Angers 1,500
Not applicableUnknownNCT05227014
What this trial is testing

Enhanced Recovery and Patient Blood Management in Colorectal Surgery

Who this might be right for
Anastomotic LeakColorectal NeoplasmsBlood Transfusion Complication+1 more
Ospedale Sandro Pertini, Roma 5,000
Testing effectiveness (Phase 2)Study completedNCT06897748
What this trial is testing

Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 98
Large-scale testing (Phase 3)Study completedNCT03409107
What this trial is testing

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Who this might be right for
Anaemia
GlaxoSmithKline 614
Testing effectiveness (Phase 2)Ended earlyNCT02928393
What this trial is testing

Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

Who this might be right for
Stroke
Hoffmann-La Roche 5
Early research (Phase 1)Ended earlyNCT04820621
What this trial is testing

Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment

Who this might be right for
Chronic Kidney Disease
Bayer 5
Large-scale testing (Phase 3)WithdrawnNCT01177852
What this trial is testing

Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis

Who this might be right for
InflammationCoughRhinitis
Ache Laboratorios Farmaceuticos S.A.
Testing effectiveness (Phase 2)Study completedNCT00410163
What this trial is testing

Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients

Who this might be right for
Leukaemia, Lymphocytic, Chronic
GlaxoSmithKline 61
Not applicableLooking for participantsNCT06272292
What this trial is testing

Biomechanical Investigation of Symptomatic FAI and Two Groups of Asymptomatic Controls

Who this might be right for
Femoroacetabular Impingement
Universitaire Ziekenhuizen KU Leuven 99
Large-scale testing (Phase 3)Study completedNCT02235272
What this trial is testing

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation

Who this might be right for
InflammationPainCataract
Xigen SA 339
Testing effectiveness (Phase 2)Ended earlyNCT00403234
What this trial is testing

Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement

Who this might be right for
Postoperative Pain
Purdue Pharma LP 10
Early research (Phase 1)Study completedNCT06494644
What this trial is testing

Assess the Pharmacokinetics of AZD6793 When Administered Alone and in Combination With Itraconazole in Healthy Participants.

Who this might be right for
Healthy Participants
AstraZeneca 17
Not applicableStudy completedNCT02890030
What this trial is testing

The Platinum Study Comparison Group

Who this might be right for
Testicular Neoplasms
Lawrence Einhorn 102
Large-scale testing (Phase 3)Study completedNCT02465567
What this trial is testing

Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)

Who this might be right for
COPD
Pearl Therapeutics, Inc. 8,588
Next Page